Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. Most relevant
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
2020ASTELLAS PHARMA : to acquire iota Biosciences
AQ
2020Nikkei flat as coronavirus resurgence in Europe hits sentiment
RE
2020ASTELLAS PHARMA : FibroGen to Present New Efficacy and Safety Analyses from Roxa..
AQ
2020Astellas Pharma Inc. entered into a merger agreement to acquire remaining unk..
CI
2020ASTELLAS PHARMA : to Acquire iota Biosciences
BU
2020ASTELLAS PHARMA : and Seagen Announce Positive Topline Results from Second Cohor..
AQ
2020Seagen and Astellas Pharma Inc. Announce Positive Topline Results from Second..
CI
2020ASTELLAS PHARMA : and LabCentral Announce Golden Ticket Winners, Helping Emergin..
AQ
2020ASTELLAS PHARMA : Celebrates First-Ever Virtual Day of Service to Help Non-Profi..
AQ
2020ASTELLAS PHARMA : and MBC BioLabs Announce Golden Ticket Competition to Help Bio..
AQ
2020ASTELLAS PHARMA : Real-World Evidence Studies Provide Further Insight into Negat..
AQ
2020ASTELLAS PHARMA INC. : Ex-dividend day for interim dividend
FA
2020ASTELLAS PHARMA : and University of Pittsburgh Announce Research Collaboration f..
AQ
2020ASTELLAS PHARMA INC. : - Astellas Efforts against the Spread of the Coronavirus ..
AQ
2020ASTELLAS PHARMA : Collaborates with Two Research Centers at the University of To..
AQ
2020ASTELLAS PHARMA : and Seattle Genetics Announce PADCEV Significantly Improved Ov..
AQ
2020Astellas Establishes Global Patient Centricity Leadership Structure
CI
2020ASTELLAS PHARMA : and Seattle Genetics Announce PADCEV Significantly Improved Ov..
PU
2020Japan shares rise on hopes for U.S. economy, new prime minister eyed
RE
2020Astellas Pharma Inc. cancelled the acquisition of Worldwide license of artifi..
CI
2020Japan stocks rise on U.S. data, easing concerns about new prime minister
RE
2020ASTELLAS PHARMA INC. : - Science-Based Fitness Service, Fit-eNce
AQ
2020Bayer takes on Astellas in purchase of experimental menopause relief
RE
2020ASTELLAS PHARMA : Open Innovation Challenge Astellas Rx+ Healthcare Innovation C..
AQ
2020Astellas Pharma Inc. Revises Consolidated Earnings Guidance for the Fiscal Ye..
CI
2020Astellas Pharma Inc. Reports Consolidated Financial Results for the First Qua..
CI
2020ASTELLAS PHARMA : is Awarded Grant from the U.S. National Institutes of Health t..
AQ
2020National Institute on Drug Abuse Awards Astellas Pharma Inc. Fund for Early C..
CI
2020ASTELLAS PHARMA : Named to FTSE4Good Index Series for Ninth Consecutive Year
AQ
2020ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
2020Japanese shares end almost flat just below three-month high as rally loses st..
RE
2020ASTELLAS PHARMA : Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phas..
AQ
2020Astellas Pharma Inc. Announces Roxadustat Demonstrates Non-Inferiority to Dar..
CI
2020ASTELLAS PHARMA : City of Yokohama, and Yokohama City University Developed Scien..
AQ
2020ASTELLAS PHARMA : Federal Circuit Reverses PTAB Finding Tarceva« Method Of Treat..
AQ
2020Pfizer Inc. and Astellas Pharma Inc. Announce Final Results from the Overall ..
CI
2020Astellas Pharma Inc. Announces Approval of XTANDI by Japan MHLW for the Treat..
CI
2020ASTELLAS PHARMA INC. : - FDA Approves VESIcare LS Oral Suspension for Pediatric ..
AQ
2020FDA Approves VESIcare LS (solifenacin succinate) Oral Suspension for Pediatri..
CI
2020ASTELLAS PHARMA INC. : - Notice Regarding Continuation of the Performance-linked..
AQ
2020ASTELLAS PHARMA : European Medicines Agency Accepts Astellas Marketing Authoriza..
AQ
2020European Medicines Agency Accepts Astellas' Marketing Authorization Applicati..
CI
2020ASTELLAS PHARMA : Immunomic Therapeutics, Inc. - Maryland's Immunomic Therapeuti..
AQ
2020Astellas Pharma Inc. Reports Consolidated Earnings Results for the Year Ended..
CI
2020Astellas Pharma Inc. Announces Dividend for the Year Ended March 31, 2020, Pa..
CI
2020Harvard Enters into Research Alliance with Astellas
CI
2020ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
2020Harvard University and Astellas Pharma Inc. Establish Strategic Research Alli..
CI
2020ASTELLAS PHARMA : and Harvard Establish Strategic Research Alliance
PU
2020ASTELLAS PHARMA INC. : - Change of Directors and Organizational Change
AQ
2020Astellas Pharma Inc. Announces Directorate and Committee Resignations
CI
2020Cytokinetics, Incorporated and Astellas Pharma Inc. Enter into Two Agreements
CI
2020ASTELLAS PHARMA : Announces Acquisition of Nanna
AQ
2020ASTELLAS PHARMA : Announces Acceptance of XOSPATA for Regulatory Review in China..
AQ
2020Astellas Pharma Inc. Announces Acceptance of XOSPATA (Gilteritinib) for Regul..
CI
2020Astellas and BANDAI NAMCO Entertainment Enter into Agreement to Co-Develop an..
CI
2020ASTELLAS PHARMA : and BANDAI NAMCO Entertainment Enter into Agreement to Co-Deve..
AQ
2020ASTELLAS PHARMA : Three Astellas Research and Production Facilities in Japan Ado..
PU
2020ASTELLAS PHARMA : Launches its Corporate Website's Science Section
PU
2020ASTELLAS PHARMA INC. : Ex-dividend day for final dividend
FA
2020CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop ..
AQ
2020CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop ..
CI
2020ASTELLAS PHARMA : CytomX Therapeutics and Astellas Announce Strategic Collaborat..
PU
2020Gifu University and Astellas Establish a Research Course on Phage Biologics, ..
CI
2020ASTELLAS PHARMA : Gifu University and Astellas establish a Research Course on Ph..
AQ
2020ASTELLAS PHARMA : Notice Regarding the Performance-linked Stock Compensation Sch..
PU
2020Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation fo..
AQ
2020ASTELLAS PHARMA : and Seattle Genetics Receive FDA Breakthrough Therapy Designat..
PU
2020ASTELLAS PHARMA : XTANDI Demonstrates Significant Improvement in Overall Surviva..
AQ
2020SEATTLE GENETICS : and Astellas Announce Updated Results from Phase 1b/2 Trial o..
AQ
2020Astellas Pharma Inc and Pfizer Inc. Announces XTANDI« (Enzalutamide) Demonstr..
CI
2020ASTELLAS PHARMA : Announces Management Structure
AQ
2020ASTELLAS PHARMA : Announces Completion of Acquisition of Own Shares, and Cancell..
PU
2020Tranche Update on Astellas Pharma Inc.'s Equity Buyback Plan announced on Oct..
CI
2020ASTELLAS PHARMA : Submits Supplemental New Drug Application for Approval of Evre..
AQ
Prev.1  2   3  4  5  6  7  8  9  10Next
Upcoming event on ASTELLAS PHARMA INC.